Adaptimmune Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $40k | 50k | 0.80 |
| 2023-09-30 | $39k | 50k | 0.78 |
| 2023-06-30 | $46k | 50k | 0.92 |
| 2022-09-30 | $366k | 340k | 1.08 |
| 2022-06-30 | $430k | 253k | 1.70 |
| 2021-09-30 | $0 | 11 | 0.00 |
| 2021-06-30 | $0 | 49 | 0.00 |
| 2021-03-31 | $43k | 8.2k | 5.27 |
| 2020-12-31 | $43k | 8.0k | 5.41 |
| 2020-09-30 | $59k | 7.4k | 7.97 |
| 2020-06-30 | $74k | 7.4k | 10.00 |
| 2020-03-31 | $20k | 7.4k | 2.70 |
| 2019-12-31 | $999 | 526 | 1.90 |
| 2019-09-30 | $2.0k | 1.6k | 1.22 |
| 2019-03-31 | $4.0k | 871 | 4.59 |
| 2018-12-31 | $2.0k | 271 | 7.38 |
| 2018-09-30 | $999 | 58 | 17.24 |
| 2018-06-30 | $417k | 35k | 11.88 |
| 2018-03-31 | $404k | 36k | 11.23 |
| 2017-12-31 | $234k | 35k | 6.67 |
| 2017-09-30 | $308k | 38k | 8.19 |